Related Experiment Videos
Uveal Melanoma Treatment and Prognostication
Mehmet Dogrusöz1, Martine J Jager1, Bertil Damato2
1Department of Ophthalmology, LUMC, Leiden, The Netherlands.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)
|April 12, 2017
Summary
Uveal melanoma, a rare eye cancer, is primarily treated with radiotherapy and laser therapy to preserve vision. Prognosis is improved by combining clinical, histologic, and genetic factors to predict metastasis.
Area of Science:
- Ophthalmology
- Oncology
- Genetics
Background:
- Uveal melanoma is the most common primary intraocular malignancy.
- Most cases (90%) arise in the choroid, with others in the ciliary body or iris.
Purpose of the Study:
- To review current treatment strategies for uveal melanoma.
- To discuss factors influencing prognosis and metastasis.
- To highlight research directions for metastatic disease.
Main Methods:
- Review of established and emerging treatments for uveal melanoma.
- Analysis of clinical, histological, and genetic prognostic factors.
- Discussion of surveillance and patient counseling strategies.
Main Results:
- Eye-sparing treatments like radiotherapy and laser therapy are preferred over enucleation.
- Various surgical techniques exist, with varying levels of complexity and controversy.
- Prognostic factors include age, tumor size, ciliary body involvement, cytomorphology, genetic alterations (e.g., chromosome 3 loss, 8q gain), and BAP1 status.
Conclusions:
- Multivariate analysis of clinical, histological, and genetic factors enhances prognostic accuracy.
- Long-term surveillance is crucial for detecting recurrence and complications.
- Developing effective treatments for metastatic uveal melanoma remains a critical research focus.